Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04557553 · ClinicalTrials.gov registry record · NA
Effects of Lagenbone on Bone Mineral Density
A NA study of Osteoporosis, sponsored by Southern California University of Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT04557553: Completed NA study of Osteoporosis, sponsored by Southern California University of Health Sciences.
NCT04557553 is a NA study of Osteoporosis that has completed, run by Southern California University of Health Sciences. The registered enrollment target is 10 participants, below the 1,546-participant average among 84 other Osteoporosis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04557553, a NA study of Osteoporosis, has completed, sponsored by Southern California University of Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
To study the effects of the herbal supplement Lagenbone on Bone Mineral Density
Primary Outcome
Dual-energy x-ray absorptiometry (DXA) or bone densitometry or Bone Density Scan
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Lagenbone
Study Locations (1)
California
- Southern California University of Health Sciences - Whittier
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-07-15 |
| Est. Completion | 2022-07-13 |
| Phase | NA |
What the finished NCT04557553 record still lists
NCT04557553 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,546-participant average among 84 other Osteoporosis trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Osteoporosis appearing as the primary indexed condition, and to 1 intervention - of which Lagenbone is the first listed.
NCT04557553 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04557553 about?
NCT04557553 is a clinical study titled "Effects of Lagenbone on Bone Mineral Density". To study the effects of the herbal supplement Lagenbone on Bone Mineral Density
What is the current status of trial NCT04557553?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-07-15. Estimated completion is 2022-07-13.
What conditions does trial NCT04557553 study?
This clinical trial studies the following conditions: Osteoporosis.
What interventions are being tested in trial NCT04557553?
The interventions under investigation include: Lagenbone (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04557553?
This trial is sponsored by Southern California University of Health Sciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04557553 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoporosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04557553's enrollment target sits among peer trials
10 83rd of 84 higher than 1 of 84 other Osteoporosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoporosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
OsteoPorotic fracTure preventION System (OPTIONS) Research Study
RECRUITING · NA
-
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
RECRUITING · NA
-
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
RECRUITING · NA
-
Mode of Exercise and Bone Biomarkers in Older Veterans
RECRUITING · NA
-
Synbiotic to Attenuate Resorption of the Skeleton
RECRUITING · NA
-
Sickle Cell Disease (SCD) Bone Pain Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI